Target intelligence / Profile preview

TBC domain family member 3 pseudogene 3 (TBC1D3P3)

Target
TBC1D3P3
Molecular classification
Other, Pseudogene
01

Overview

TBC1 domain family member 3 pseudogene 3 (TBC1D3P3, ENSG00000278160) is a human pseudogene classified by HGNC as non-protein-coding[3]. Pseudogenes are genomic DNA sequences similar to functional genes but typically lack protein-coding potential due to mutations or lack of expression[3]. TBC1D3P3 shows sequence similarity to the TBC1D3 gene family, which in functional members is involved in GTPase signaling and vesicle trafficking[2]. However, as a pseudogene, TBC1D3P3 is not believed to encode a functional protein or possess recognized biological functions, disease roles, or clinical relevance as a therapeutic target[3][1]. The Ensembl gene ID ENSG00000278160 matches TBC1D3P3, confirmed as a pseudogene by academic and commercial databases[3][1]. Pseudogenes like TBC1D3P3 may impact genomic regulation or expression patterns, but do not act as receptors, enzymes, or direct therapeutic targets[1][3]. No evidence links TBC1D3P3 to disease, drug interaction, or molecular function as with other TBC1D3 gene family members[3][1]. By convention, pseudogene entries are not considered therapeutic targets and have limited direct biomedical application. TBC1D3P3 is a pseudogene, not a protein or receptor, and thus not a drug target[3][1]. There is no evidence of disease or drug associations. The entry is accurate in nomenclature, but as a pseudogene, it does not meet the criteria for a therapeutic target. If you intended a protein-coding gene from the TBC1D3 family (such as TBC1D3B), those have function as GTPase-activating proteins for RAB GTPases and potential disease associations[2], but the specific queried pseudogene (ENSG00000278160, TBC1D3P3) lacks such attributes[3][1].

Other names
TBC1D3P3TBC1 domain family member 3 pseudogene 3

Beyond the preview

Go deeper on TBC domain family member 3 pseudogene 3 (TBC1D3P3).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on TBC domain family member 3 pseudogene 3 (TBC1D3P3).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call